Tokio Marine Asset Management CO LTD Alkermes Plc. Transaction History

Tokio Marine Asset Management CO LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$26.4 - $30.54 $13,200 - $15,270	-500 Reduced 5.43%	8,700 $259,000
Q1 2022 May 13, 2022	SELL	$23.07 - $27.99 $46,140 - $55,980	-2,000 Reduced 17.86%	9,200 $242,000
Q4 2021 Jan 26, 2022	SELL	$21.47 - $32.08 $47,234 - $70,576	-2,200 Reduced 16.42%	11,200 $261,000
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $14,022 - $19,278	-600 Reduced 4.29%	13,400 $413,000
Q2 2021 Aug 12, 2021	BUY	$18.78 - $25.15 $262,920 - $352,100	14,000 New	14,000 $343,000

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.